search
Back to results

Treatment of Abdominal Distension by Biofeedback - a Randomized Controlled Trial

Primary Purpose

Irritable Bowel Syndrome, Dyspepsia

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Bio-feedback
Placebo
Sponsored by
Hospital Universitari Vall d'Hebron Research Institute
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Irritable Bowel Syndrome focused on measuring Gastrointestinal Diseases, Irritable Bowel Syndrome, Behavioral Research, Biofeedback

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: episodes of visible abdominal distension triggered by meal ingestion

Exclusion Criteria: organic cause detected by clinical work-up

Sites / Locations

  • University Hospital Vall d'Hebron

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

Biofeedback

Placebo medication

Arm Description

Patients will be taught to control abdominal and diaphragmatic muscles by bio-feedback using EMG recordings.

Electromyography will be recorded but not shown to the patients. Patients will take a pill of placebo.

Outcomes

Primary Outcome Measures

Sensation of abdominal distension
Sensation score measured by 0-6 scales after each meal (breakfast, lunch, dinner) over a 10-day clinical evaluation period before and after intervention.

Secondary Outcome Measures

Changes in thoraco-abdominal activity of the muscular walls.
Activity of thoraco-abdominal muscles (intercostals, diaphragm, external oblique, internal oblique, upper rectus, lower rectus) will be continuously measured by electromyography.
Changes in girth
Abdominal girth will be continuously measured using a nonstretch belt (48mm wide) that is placed over the umbilicus and fixed to the skin on the back to prevent slipping. The overlapping ends of the belt will be adjusted carefully with two elastic bands to adapt constantly to the abdominal wall. Measurements will be taken before and at the beginning at the end of each intervention session.

Full Information

First Posted
September 6, 2010
Last Updated
July 26, 2016
Sponsor
Hospital Universitari Vall d'Hebron Research Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT01205100
Brief Title
Treatment of Abdominal Distension by Biofeedback - a Randomized Controlled Trial
Official Title
Feedback-assisted Treatment of Abdominal Distension - a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
July 2016
Overall Recruitment Status
Completed
Study Start Date
January 2013 (undefined)
Primary Completion Date
January 2016 (Actual)
Study Completion Date
June 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospital Universitari Vall d'Hebron Research Institute

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Background: Abdominal bloating is a frequent and bothersome complaint in patients with functional gut disorders without satisfactory treatment to date. Recent data from our laboratory indicate that abdominal distention in these patients is produced by abdomino-phrenic dyssynergia: diaphragmatic contraction associated with abdominal wall relaxation (particularly the internal oblique). In analogy to other clinical situations (e.g. functional outlet obstruction, rumination or aerophagia) behavioral treatment by means of biofeedback might be equally effective in these patients. The investigators hypothesized that abdomino-phrenic coordination and abdominal distention can be controlled by biofeedback techniques. Aim: to prove the efficacy of behavioural treatment using biofeedback techniques for abdominal distension. Randomization: Patients will be randomized into biofeedback and placebo groups. Intervention. Biofeedback: patients will be taught to control abdominothoracic muscular activity by bio-feedback using online electromyography information. Placebo: patients will be given a pill containing placebo medication. Interventions will be delivered in 3 sessions (20 min each) over 10-day period . Measurements: Sensation of abdominal distension will be assessed by means of graphic rating scales graded from 0 (no perception) to 6 (very intense sensation). The activity of the abdomino-thoracic muscles will be recorded. Abdominal distension will be measured by a metric tape fixed to a non-stretch belt placed over the umbilicus. Outcomes: Primary outcome: Change in sensation of abdominal sensation. Secondary outcomes: a) changes in thoraco-abdominal activity of the muscular walls; activity of thoraco-abdominal muscles (intercostals, diaphragm, external oblique, internal oblique, upper rectus, lower rectus) will be measured by electromyography; b) changes in girth; abdominal girth will be measured using a nonstretch belt (48mm wide) that is placed over the umbilicus. The overlapping ends of the belt will be adjusted carefully with two elastic bands to adapt constantly to the abdominal wall.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Irritable Bowel Syndrome, Dyspepsia
Keywords
Gastrointestinal Diseases, Irritable Bowel Syndrome, Behavioral Research, Biofeedback

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
48 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Biofeedback
Arm Type
Active Comparator
Arm Description
Patients will be taught to control abdominal and diaphragmatic muscles by bio-feedback using EMG recordings.
Arm Title
Placebo medication
Arm Type
Placebo Comparator
Arm Description
Electromyography will be recorded but not shown to the patients. Patients will take a pill of placebo.
Intervention Type
Behavioral
Intervention Name(s)
Bio-feedback
Intervention Description
By providing on-line electromyography information of muscle activity, patients will be able to control and actively correct their muscle activity during the 15 min treatment session. Each patients will attend 3 treatment sessions.
Intervention Type
Drug
Intervention Name(s)
Placebo
Primary Outcome Measure Information:
Title
Sensation of abdominal distension
Description
Sensation score measured by 0-6 scales after each meal (breakfast, lunch, dinner) over a 10-day clinical evaluation period before and after intervention.
Time Frame
10 days
Secondary Outcome Measure Information:
Title
Changes in thoraco-abdominal activity of the muscular walls.
Description
Activity of thoraco-abdominal muscles (intercostals, diaphragm, external oblique, internal oblique, upper rectus, lower rectus) will be continuously measured by electromyography.
Time Frame
10 days
Title
Changes in girth
Description
Abdominal girth will be continuously measured using a nonstretch belt (48mm wide) that is placed over the umbilicus and fixed to the skin on the back to prevent slipping. The overlapping ends of the belt will be adjusted carefully with two elastic bands to adapt constantly to the abdominal wall. Measurements will be taken before and at the beginning at the end of each intervention session.
Time Frame
10 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: episodes of visible abdominal distension triggered by meal ingestion Exclusion Criteria: organic cause detected by clinical work-up
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Fernando Azpiroz, M.D.
Organizational Affiliation
University Hospital Vall d'Hebron
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital Vall d'Hebron
City
Barcelona
State/Province
Catalunya
ZIP/Postal Code
08035
Country
Spain

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Publication in scientific journal.
Citations:
PubMed Identifier
16618400
Citation
Tremolaterra F, Villoria A, Azpiroz F, Serra J, Aguade S, Malagelada JR. Impaired viscerosomatic reflexes and abdominal-wall dystony associated with bloating. Gastroenterology. 2006 Apr;130(4):1062-8. doi: 10.1053/j.gastro.2005.12.036.
Results Reference
background
PubMed Identifier
18786126
Citation
Villoria A, Azpiroz F, Soldevilla A, Perez F, Malagelada JR. Abdominal accommodation: a coordinated adaptation of the abdominal wall to its content. Am J Gastroenterol. 2008 Nov;103(11):2807-15. doi: 10.1111/j.1572-0241.2008.02141.x. Epub 2008 Sep 10.
Results Reference
background
PubMed Identifier
28705783
Citation
Barba E, Accarino A, Azpiroz F. Correction of Abdominal Distention by Biofeedback-Guided Control of Abdominothoracic Muscular Activity in a Randomized, Placebo-Controlled Trial. Clin Gastroenterol Hepatol. 2017 Dec;15(12):1922-1929. doi: 10.1016/j.cgh.2017.06.052. Epub 2017 Jul 11.
Results Reference
derived

Learn more about this trial

Treatment of Abdominal Distension by Biofeedback - a Randomized Controlled Trial

We'll reach out to this number within 24 hrs